Efficient and Mild Ullmann-Type N-Arylation of Amides, Carbamates, and Azoles in Water
作者:Maud Bollenbach、Pedro G. V. Aquino、João Xavier de Araújo-Júnior、Jean-Jacques Bourguignon、Frédéric Bihel、Christophe Salomé、Patrick Wagner、Martine Schmitt
DOI:10.1002/chem.201700832
日期:2017.10.4
A simple, sustainable, efficient, mild, and low‐cost protocol was developed for d‐glucose‐assisted Cu‐catalyzed Ullmann reactions in water for amides, carbamates, and nitrogen‐containing heterocycles. The reaction was compatible with diverse aryl/heteroaryl iodides, giving highly substituted pyridine, indole, or indazole rings. This method offers an attractive alternative to existing protocols, because
BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS
申请人:Galley Guido
公开号:US20090036420A1
公开(公告)日:2009-02-05
The present invention relates to methods of treating CNS disorders with a compound of formula I
wherein
X, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, and R
8
are as defined in the specification and pharmaceutically acceptable acid addition salts thereof.
Substituted cyclic amine compounds as 5HT2 antagonists
申请人:TOA EIYO LTD.
公开号:EP0661266A1
公开(公告)日:1995-07-05
A substituted cyclic amine compound represented by the following general formula (1)
wherein each of R¹ to R⁵ represents a hydrogen atom, a hydroxyl group, an alkyl group or the like, D represents a methine moiety, a nitrogen atom or the like, P represents -CR⁶(R⁷)- or -NR⁸-, Q represents a methine moiety or a nitrogen atom, each of T and B is a single bond or represents a methylene moiety, a carbonyl group or the like, n is an integer of 1 to 6 and each of R⁶, R⁷ and R⁸ represents a hydrogen atom, an alkyl group or the like; and synthetic intermediates thereof.
The inventive compound is useful in preventing and treating circulatory organ-related diseases such as hypertension, ischemic heart disease, cerebrovascular disease, peripherol circulatory disease and the like.
FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
申请人:Novogen Limited
公开号:US20170166555A1
公开(公告)日:2017-06-15
The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a proliferative disease, preferably cancer, using compounds of the invention.